Biocept Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 365.5%.

Top 22 shareholders own 8.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
5.15%	The Lind Partners, LLC	135,294	US$138.0k	0%	0.29%
1.71%	Anson Group	44,861	US$45.8k	0%	0.01%
0.9%	Boothbay Fund Management, LLC	23,529	US$24.0k	0%	no data
0.21%	Tower Research Capital LLC	5,389	US$5.5k	1,840%	no data
0.2%	BlackRock, Inc.	5,261	US$5.4k	-0.04%	no data
0.17%	Geode Capital Management, LLC	4,470	US$4.6k	0%	no data
0.17%	The Vanguard Group, Inc.	4,434	US$4.5k	0%	no data
0.01%	Group One Trading LP, Asset Management Arm	270	US$275.4	1.5%	no data
0.01%	JPMorgan Chase & Co, Private Banking and Investment Banking Investments	268	US$273.5	0%	no data
0.0094%	Acadian Asset Management LLC	247	US$252.1	-46.5%	no data
0.0044%	City National Rochdale, LLC	115	US$117.3	-0.86%	no data
0.004%	Hale BioPharma Ventures LLC	104	US$106.1	0%	no data
0.0013%	Securities America Advisors, Inc.	33	US$33.7	0%	no data
0.0011%	David Hale	30	US$30.5	0%	no data
0.00072%	Michael Dugan	19	US$19.3	0%	no data
0.00069%	U.S. Bancorp Asset Management, Inc.	18	US$18.5	-5.26%	no data
0.00057%	Bruce Gerhardt	15	US$15.3	0%	no data
0.00038%	Timothy Kennedy	10	US$10.2	0%	no data
0.00015%	Wells Fargo & Company, Private Banking and Investment Banking Arm	4	US$4.0	33.3%	no data
0.00008%	Ivor Royston	2	US$2.1	0%	no data
0.00008%	M. Wilson	2	US$2.1	0%	no data
0.00004%	Marsha Chandler	1	US$1.1	0%	no data